Written by:Fact check:

Overview

What Is Idiopathic Pulmonary Fibrosis?

Idiopathic pulmonary fibrosis (IPF) is a long-term lung disease in which scar tissue gradually builds up in the lungs. “Idiopathic” means the exact cause is unknown. As scarring progresses, the lungs become stiffer and cannot transfer oxygen into the blood as efficiently. IPF most often affects older adults and can make everyday activities increasingly difficult.

Symptoms

Symptoms of Idiopathic Pulmonary Fibrosis

Pulmonary fibrosis symptoms often develop gradually and may first be mistaken for normal aging or reduced fitness. Changes can become more noticeable during walking, climbing stairs, or other physical activity.

  • A persistent dry cough.
  • Shortness of breath with activity (exertional dyspnea).
  • Tiredness that is not fully relieved by rest.
  • Reduced exercise tolerance.
  • Unintended weight loss.
  • Widened or rounded fingertips (clubbing), which may occur in some people.

When symptoms change

Get prompt medical advice

Worsening breathlessness, a new change in cough, or a sudden decline in breathing should be assessed promptly. These changes may indicate an acute exacerbation of lung fibrosis or another urgent problem.

Causes

Causes of Idiopathic Pulmonary Fibrosis

IPF has no single identified cause. Repeated injury or abnormal repair of the lining of the lung’s air sacs may cause the body to form too much scar tissue, leading to fibrosis of the lungs. The exact reasons this process begins are still being studied.

What does “idiopathic” mean?

In IPF, idiopathic means that doctors cannot identify a definite cause after evaluating other possibilities. IPF is not contagious and cannot spread from person to person. It is different from pulmonary fibrosis caused by a known medication, autoimmune disease, occupational exposure, or infection.

Risk Factors

Risk Factors for Idiopathic Pulmonary Fibrosis

  • Older age is associated with a higher likelihood of developing IPF.
  • Male sex is associated with a higher likelihood in population studies.
  • A family history of IPF or genetic susceptibility may increase risk.
  • Cigarette smoking is a potentially modifiable association.
  • Certain occupational or environmental exposures to dust, fumes, or other irritants may be associated with lung fibrosis.

Complications

Complications of Idiopathic Pulmonary Fibrosis

  • Low blood oxygen (hypoxemia) can develop as scarring limits oxygen transfer.
  • Pulmonary hypertension can occur when scarred lungs increase pressure in the blood vessels of the lungs.
  • Respiratory failure may occur when the lungs can no longer provide enough oxygen or remove enough carbon dioxide.
  • Chest infections may be more difficult to tolerate when lung function is reduced.
  • Blood clots, including clots that travel to the lungs, can cause serious breathing problems.
  • People with IPF may have an increased risk of lung cancer.
  • An acute exacerbation is a sudden, serious worsening of lung function.

Urgent symptoms

Know when complications may be developing

Sudden severe breathlessness, rapidly worsening oxygen levels, chest pain, confusion, or blue lips can signal a serious complication. Seek urgent medical care if these symptoms occur.

Diagnosis

How Idiopathic Pulmonary Fibrosis Is Diagnosed

Diagnosis usually involves a pulmonologist and may require a multidisciplinary team because IPF can resemble other interstitial lung diseases. Clinicians combine symptoms, examination findings, imaging, and test results while looking for other causes of lung fibrosis.

  • A medical, medication, family, and occupational exposure history helps identify possible causes.
  • A physical examination may detect abnormal breathing sounds or signs of low oxygen.
  • Pulmonary function tests measure breathing capacity and how well the lungs transfer oxygen.
  • Oxygen levels may be checked with a pulse oximeter at rest and during activity.
  • High-resolution CT provides detailed images that can show patterns of lung scarring.
  • Blood tests may help assess autoimmune disease, infection, or other alternative conditions.
  • Bronchoscopy or a lung biopsy may be considered in selected cases when imaging does not provide enough information.

Treatment & Management

Treatment and Management of Idiopathic Pulmonary Fibrosis

Treatment cannot usually remove existing scar tissue, but it can slow progression, relieve symptoms, preserve lung function, and support quality of life. A pulmonology team creates a plan based on symptoms, test results, other health conditions, and the person’s goals.

  • Antifibrotic medicines such as nintedanib and pirfenidone may slow disease progression; clinicians discuss expected benefits, monitoring, interactions, and side effects.
  • Medication choices should be reviewed regularly because treatment response and tolerability can change over time.
  • Pulmonary rehabilitation can support breathing, strength, and safe daily activity.
  • Supplemental oxygen may be prescribed when oxygen levels are low at rest, during activity, or during sleep.
  • Vaccinations and infection-prevention measures can reduce the risk of serious respiratory infections.
  • Stopping smoking can protect remaining lung function and improve overall health.
  • Nutrition and activity planning can help maintain strength and manage fatigue.
  • Symptom-focused palliative care can help with breathlessness, cough, anxiety, and quality of life at any stage.
  • Lung transplant referral may be appropriate for selected candidates with advanced or worsening disease.

Outlook and Prognosis

Outlook and Prognosis for Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis is chronic and usually progressive, but the rate of change varies widely. Some people experience periods of relative stability, while others develop faster worsening or sudden exacerbations. Regular follow-up helps the clinical team adjust care as the condition changes.

  • Symptoms and their effect on daily activities help clinicians assess the current disease burden.
  • Lung function results help show how breathing capacity changes over time.
  • Increasing oxygen needs may indicate worsening impairment.
  • Exercise capacity provides information about how the lungs respond to physical activity.
  • Acute exacerbations can significantly affect the disease course.
  • Other medical conditions may influence health and treatment choices.
  • Response to treatment and ability to tolerate medicines can affect ongoing management.

When Should You See a Doctor

When Should You See a Doctor for Possible IPF?

  • Arrange a medical appointment for a persistent dry cough.
  • Arrange an assessment for breathlessness that is new or worsening.
  • Discuss reduced exercise tolerance that does not improve with rest or conditioning.
  • Seek medical advice for unexplained tiredness that persists.
  • Arrange an evaluation for unexplained weight loss.

Get urgent help

Emergency warning signs

Contact emergency services for severe or sudden breathing difficulty, blue or gray lips, fainting, confusion, severe chest pain, or rapidly worsening symptoms.

People with a known diagnosis should contact their clinical team promptly if breathing, cough, oxygen readings, or exercise ability changes suddenly. Early assessment can help identify an acute exacerbation, infection, clot, or another problem requiring treatment.

Branches

1 topic

Symptoms

1 topic